Shiho Iwagaitsu

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 88 citations · Full text

Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still’s disease

Taio Naniwa, Rei Ito, Maiko Watanabe et al. · Clinical Rheumatology · 2010 · 21 citations

Rheumatology, Allergy, Autoimmune Disease +6

Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim therapy for Pneumocystis jirovecii pneumonia in patients with systemic rheumatic diseases: A retrospective multicenter study

Shin‐ichiro Ohmura, Taio Naniwa, Shin‐ya Tamechika et al. · Journal of Infection and Chemotherapy · 2019 · 20 citations

Rheumatology, Pneumocystis Jirovecii Pneumonia, Systemic Rheumatic Diseases +8

Oral candidiasis is a significant predictor of subsequent severe infections during immunosuppressive therapy in anti-neutrophil cytoplasmic antibody-associated vasculitis

Makoto Yamaguchi, Takayuki Katsuno, Shiho Iwagaitsu et al. · BMC Infectious Diseases · 2019 · 18 citations · Full text

Anti-neutrophil cytoplasmic antibody-associated vasculitis complicated by thrombotic microangiopathy with posterior reversible encephalopathy syndrome successfully treated with eculizumab: A case report

Fumiya Kitamura, Makoto Yamaguchi, Minori Nishimura et al. · Modern Rheumatology Case Reports · 2022 · 16 citations